BioMarin Pharmaceutical Inc. (BMRN): A Potential 10x Investment by 2030
BioMarin's innovative pipeline may lead to significant stock growth by 2030, focusing on therapies for rare genetic diseases.
Editorial Staff 12 days ago
#Pharmaceuticals
3 articles tagged with "Pharmaceuticals"
Replimune's Drug Faces Third FDA Approval Attempt Amid Pfizer's New Deal in China
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
Editorial Staff 14 days ago